To further evaluate the role of IFN signaling on MDSC function and tumor control, therapeutic efficacy of poly(I:C)c treatment was assessed in PDAC-bearing wild-type and IFNAR1-deficient mice. The gene discussed is IFNAR1; the disease is neoplasm.